Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures.

Epilepsia · 2018 · PMC6033043 · PMID 29727013

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Results There was a strong, consistent, and highly significant relationship between everolimus exposure and efficacy, measured by TN ‐ C min and SF , regardless of patient's age and concomitant use of cytochrome P450 3A4 (CYP3A4) inhibitors/inducers.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.